A Datasheet for the INSIGHT University Hospitals Birmingham Retinal Vein Occlusion Data Set

Purpose: Retinal vein occlusion (RVO) is the second leading cause of visual loss due to retinal disease. Retinal vein occlusion increases the risk of cardiovascular mortality and the risk of stroke. This article describes the data contained within the INSIGHT eye health data set for RVO and cardiovascular disease.Design: Data set descriptor for routinely collected eye and systemic disease data.Participants: All people who had suffered an RVO aged >= 18 years old, attending the Ophthalmology Clinic at Queen Elizabeth Hospital, University Hospitals Birmingham (UHB) National Health Service (NHS) Trust were included.Methods: The INSIGHT Health Data Research Hub for Eye Health is an NHS-led ophthalmic bioresource. It provides researchers with safe access to anonymized routinely collected data from contributing NHS hospitals to advance research for patient benefit. This report describes the INSIGHT UHB RVO and major adverse cardio-vascular events data set, a data set of ophthalmology and systemic data derived from the United Kingdom's largest acute care trust.Main Outcome Measures: This data set consists of routinely collected data from the hospital's electronic patient records. The data set primarily includes structured data (relating to their hospital eye care and any car-diovascular data held for the individual) and OCT ocular images. Further details regarding the available data points are available in the supplementary information.Results: At the time point of this analysis (September 30, 2022) the data set was composed of clinical data from 1521 patients, from Medisoft records inception. The data set includes 2196 occurrences of RVO affecting 2026 eyes, longitudinal eye follow-up clinical parameters, over 6217 eye-related procedures, and 982 encoun-tered complications. The data set contains information on 2534 major adverse cardiovascular event occurrences, their subtype, number experienced per patient, and chronological relation to RVO event. Longitudinal follow-up data including laboratory results, regular medications, and all-cause mortality are also available within the data set.Conclusions: This data set descriptor article summarizes the data set contents, the process of its curation, and potential uses. The data set is available through the structured application process that ensures research studies are for patient benefit.

Automated summary

This article describes the data set for retinal vein occlusion (RVO) and cardiovascular disease in the INSIGHT eye health data set. The data set contains a large amount of clinical data and ocular images, which can be used for research and improvement of patient treatment and prognosis.